Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Scholar Rock presents SRK-015 data
September 2020
SHARING OPTIONS:

CAMBRIDGE, Mass.—Scholar Rock presented data on pipeline candidate SRK-015 for treatment of patients with type 2 and type 3 spinal muscular atrophy (SMA) as part of the 2020 Virtual Cure SMA Research and Clinical Care Meeting. The two presentations reviewed previously presented data from preclinical studies: the Phase 1 healthy volunteer trial, and preliminary pharmacokinetic and biomarker data and baseline demographics from the TOPAZ Phase 2 trial.

Back



PAGE UTILITIES


CONTACT US
DDNEWS
1000 N West Street, Suite 1200,
Wilmington, Delaware, 19801
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.